[SINGAPORE] A unit of embattled entertainment group mm2 Asia has received a payment demand for S$6.3 million, the company ...

A unit of mm2 Asia, the former Cathay Cineplexes operator, receives a significant payment demand from a creditor amid parent ...

[SINGAPORE] A unit of embattled entertainment group mm2 Asia on Monday (Dec 29) said it has received a payment demand for ...

SINGAPORE: Cinema operator mm2, which owes millions of dollars to creditors, was on Wednesday (Dec 10) given a nod by the High Court to apply for a four-month moratorium. The Singapore company has ...

SINGAPORE – Former Cathay Cineplexes operator mm2 Asia has been given a lifeline after the High Court on Dec 10 allowed the company to be shielded from creditors and legal proceedings for four months ...

Shares in MM2 Asia closed 0.1 cent lower or 25% down at 0.3 cents on Nov 10. MM2 Asia has requested a voluntary suspension of the trading of its shares “with immediate effect” on Nov 11. This comes ...

SINGAPORE: Cathay Cineplexes owner mm2 Asia saw its group net loss surge to S$122.4 million (US$95.4 million) in the 2025 fiscal year, financial results showed on Thursday (Aug 28), a substantial ...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you design and create an advertising campaign, in print and digital, on this ...

Follow us on Facebook and join our Telegram channel for the latest updates. There's a fine line between high hopes and unrealistic expectations. For shareholders of mm2 Asia, that subtle distinction ...

Mired in millions of dollars in debt, Cathay Cineplexes' parent company mm2 Asia said on Thursday (July 17) that it is considering closing its cinema business. CNA reported that winding up one of ...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you design and create an advertising campaign, in print and digital, on this ...

Regeneron Pharmaceuticals announced initial results from the Phase 1b LINKER-MM2 trial evaluating linvoseltamab, used in combination with carfilzomib or bortezomib, for patients with ...